Beryl Drugs Ltd
Know More24.10↑1.14 (4.97%)
04:01 PM,4th Dec 2023BSE : 524606
NSE :
Sector : Health care
ISIN Code : INE415H01017
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: Dec 04 2023 | 04:01 PM IST
| Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Beryl Drugs Ltd
Beryl Drugs Ltd is engaged in the manufacture sale and export of branded generic pharmaceutical formulations in India and internationally. It offers I.V.fluids and a range of small and large volume injectables. The company also provides a range of eye/ear drops veterinary products and injections. It sells its products through its sales and distribution network. In addition the company offers research and development as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore India.Beryl Drugs Ltd was incorporated as a public limited company on August 24 1993. The company has taken over the running business of M/s Flora and Fauna Remedies on December 15 1993. The shares of Beryl Drugs were listed on M.P. Stock Exchange Bombay Stock Exchange and Ahmedabad Stock Exchange.Beryl has emerged into a global network of pharmaceutical manufacturing research and development contract manufacturing services and veterinary products. The manufacturing facilities of the company are in compliance with WHO GMP specifications.The company owns brands like BERI-CEF injection F-Neuron Amplicillin INJ P-Mol Biprox B-Flox and many more.The company has received ISO 9001:2000 certification for its quality management.
News
View MoreAnnouncement
View MoreBeryl Drugs Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 12 |
| EPS - TTM (₹) [S] | 1.99 |
| P/E Ratio (X) [S] | 1.36 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | - |
| Book Value Share (₹) [S] | 17.73 |
| P/B Ratio (₹) [S] | 1.36 |
| [*C] Consolidated [*S] Standalone | |
Funds Owing this Stock
| Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
|---|
Research Reports
| Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
|---|---|---|---|---|
| Data Not Found |
Stock Strength
| Today's Low/High | 23.00 24.10 |
| Week Low/High | 20.19 24.10 |
| Month Low/High | 19.35 24.10 |
| Year Low/High | 11.05 25.00 |
| All time Low/High | 0.60 53.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 17.05% | % | 4.39 | 4.51% |
| 1 Month | 15.31% | % | 6.99 | 7.57% |
| 3 Month | 1.73% | % | 4.93 | 5.93% |
| 6 Month | 64.62% | % | 10.10 | 11.61% |
| 1 Year | 101.00% | % | 9.54 | 10.65% |
| 3 Year | 244.29% | % | 52.76 | 56.03% |
Company Info
Company Information
ED / MD / Promoter : Sanjay Sethi
Chairman & Non Executive Dir. : Sudhir Sethi
Independent Non Exe. Director : Abhinav Naik
Independent Non Exe. Director : Shreya Saraf
Registered Office: 133 Kanchan Bag, ,Indore,Madhya Pradesh-452001 Ph: 91-731-25076375/3046366
Email:beryldrugs25@yahoo.com
